Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-16-026220
Filing Date
2016-02-29
Accepted
2016-02-26 18:35:47
Documents
81
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K insy20151231_10k.htm 10-K 2705515
2 EXHIBIT 10.12 ex10-12.htm EX-10.12 305047
3 EXHIBIT 21.1 ex21-1.htm EX-21.1 4650
4 EXHIBIT 23.1 ex23-1.htm EX-23.1 3689
5 EXHIBIT 31.1 ex31-1.htm EX-31.1 19310
6 EXHIBIT 31.2 ex31-2.htm EX-31.2 17508
7 EXHIBIT 32 ex32.htm EX-32 9270
14 image2.jpg GRAPHIC 30845
15 image1.jpg GRAPHIC 8916
  Complete submission text file 0001437749-16-026220.txt   9817265

Data Files

Seq Description Document Type Size
8 EXHIBIT 101.INS insy-20151231.xml EX-101.INS 2033904
9 EXHIBIT 101.SCH insy-20151231.xsd EX-101.SCH 61485
10 EXHIBIT 101.CAL insy-20151231_cal.xml EX-101.CAL 58213
11 EXHIBIT 101.DEF insy-20151231_def.xml EX-101.DEF 460943
12 EXHIBIT 101.LAB insy-20151231_lab.xml EX-101.LAB 419674
13 EXHIBIT 101.PRE insy-20151231_pre.xml EX-101.PRE 494576
Mailing Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044
Business Address 10220 SOUTH 51ST STREET SUITE 2 PHOENIX AZ 85044 602-910-2617
Insys Therapeutics, Inc. (Filer) CIK: 0001516479 (see all company filings)

EIN.: 510327886 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35902 | Film No.: 161464173
SIC: 2834 Pharmaceutical Preparations